Frank Mott

6PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Aboriginal and Torres Strait Islander and disabilityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 10, 2023
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma.

Renata Ferrarotto, Luana G Sousa, Lei Feng

|Sep 22, 2021
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.

Yasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter

|Dec 28, 2020
Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI).

Frank E Mott, Ruth Sacks, Faye Johnson

|Aug 12, 2020
Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center.

Richard C Cardoso, Mona Kamal, Jhankruti Zaveri

|Jul 07, 2017
Patient Reported Outcomes (PROs) as Part of Value-Based Care Can Shape Therapy Guidelines: Impact on Emerging Targeted Agents and Immunotherapy Protocols in Resource-Limited Regions.

Frank E Mott

Pageof 1

Frequent Collaborators

2 joint publications

Katherine A Hutcheson

2 joint publications

Yasir Y Elamin

1 joint publications

Richard C Cardoso

1 joint publications

Mona Kamal